It is getting pretty thin in analyst coverage as we get closer to Labor Day, but these are the upgrades and downgrades we are seeing this Wednesday morning:

Exponent (EXPO) Started as Buy at SunTrust.
eHealth (EHTH) Started as Buy at Merriman Curhan Ford.
Incyte (INCY) Started as Buy at Citigroup.
Rigel (RIGL) Started as Buy at Citigroup.
Wimm-Bill-Dann Foods (WBD) Raised to Buy at UBS.
AMR (AMR) Cut to Sell at Citigroup.
Amylin Pharma (AMLN) Cut to Neutral at Baird.
BankUnited (BKUNA) Cut To Sell at Stifel Nicolaus.
National Grid (NGG) Cut to Equal Weight at Lehman.

Jon C. Ogg
August 27, 2008

Smart Investors Are Quietly Loading Up on These “Dividend Legends”

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.

There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.

If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Thanks! We will redirect you shortly to the free report!

By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.